TipRanks
Innovent Biologics (MX:1801N)
:1801N
Mexico Market
1801N
Innovent Biologics
RESEARCH TOOLSreports

Innovent Biologics (1801N) Stock News & Sentiment

1 Followers
Innovent Wins China Approval for Jaypirca in All Lines of CLL/SLL Therapy
Premium
Company Announcements
Innovent Wins China Approval for Jaypirca in All Lines of CLL/SLL Therapy
4d ago
Innovent Biologics Grants Share Options and Restricted Shares Under 2024 Scheme
Premium
Company Announcements
Innovent Biologics Grants Share Options and Restricted Shares Under 2024 Scheme
1M ago
Innovent Biologics Details Board and Committee Structure
Premium
Company Announcements
Innovent Biologics Details Board and Committee Structure
1M ago
Analyst Jill Wu Raises Target Price and Reiterates Buy on Innovent Biologics After Strong 1H26 Beat and Robust Growth Outlook
Premium
Ratings
Analyst Jill Wu Raises Target Price and Reiterates Buy on Innovent Biologics After Strong 1H26 Beat and Robust Growth Outlook
1M ago
Jack Lin Reiterates Buy on Innovent Biologics, Citing Strong Profitability, Solid Revenue Growth, and De-Risked Late-Stage Pipeline
Premium
Ratings
Jack Lin Reiterates Buy on Innovent Biologics, Citing Strong Profitability, Solid Revenue Growth, and De-Risked Late-Stage Pipeline
1M ago
Innovent Biologics Reshapes Board Roles as Veteran Executive Retires from Full-Time Post
Premium
Company Announcements
Innovent Biologics Reshapes Board Roles as Veteran Executive Retires from Full-Time Post
1M ago
Innovent Biologics Delivers Strong First-Half 2026 Profit and Revenue Surge
Premium
Company Announcements
Innovent Biologics Delivers Strong First-Half 2026 Profit and Revenue Surge
1M ago
More MX:1801N News >

1801N News on the Web

Innovent Biologics announces expansion of global Phase 3 MarsLight-11 trial
TipRanks News
Bullish
Bernstein Sticks to Its Buy Rating for Innovent Biologics (IVBXF)
TipRanks News
Bullish
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals\n
CNBC
Bullish
Citic Securities Sticks to Its Buy Rating for Innovent Biologics (IVBXF)
TipRanks News
Neutral
Huatai Securities Sticks to Their Buy Rating for Innovent Biologics (IVBXF)
TipRanks News
Bullish
UBS Keeps Their Buy Rating on Innovent Biologics (IVBXF)
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990), Innovent Biologics (IVBXF)
TipRanks News
Bullish
Analyst Jill Wu Raises Target Price and Reiterates Buy on Innovent Biologics After Strong 1H26 Beat and Robust Growth Outlook
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
MX:1801N
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is MX:1801N’s Media Buzz Sentiment?
3 articles about MX:1801N were published this week. In an average week, 2.5 articles are published.
    What is MX:1801N’s weekly average amount of articles?
    In an average week, 2.5 articles about MX:1801N are published.
      What is MX:1801N’s News Sentiment?
      100% of articles about MX:1801N were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        HUMHumana
        ACETAdicet Bio
        ZYMEZymeworks
        RHHBYRoche Holding
        QTTBQ32 Bio
        Showing the stocks with the most bullish news sentiment over the past week